ACADIA HEALTHCARE CO (ACHC) is down -16.34% in the latest session. Our newswire has captured 4 stories on ACHC across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 53/100).
ACHC stock is down 16.34% as of the close at $27.35. The drop follows the release of second-quarter 2026 earnings and guidance updates by Acadia Healthcare. While the company raised full-year adjusted EPS and revenue guidance, the market reacted negatively to the revised forecast and the broader financial picture.
Acadia Healthcare reported Q2 2026 results and updated its full-year 2026 guidance. The company raised its adjusted EPS guidance from $1.35-$1.60 to $1.45-$1.60, and its revenue guidance from $3.370B-$3.450B to $3.400B-$3.450B. However, the stock declined sharply following the earnings call and related disclosures. The company emphasized free cash flow and EBITDA performance, as well as plans for bed expansion, but the market appeared to focus on underlying profitability challenges. An SEC 8-K filing on July 28 detailed the company’s results of operations and financial condition, including a negative net margin and unprofitable earnings per share. The Q2 earnings call transcript and slide deck, published on July 29, further outlined key risks and financial updates.
Acadia Healthcare has a market cap of $3.0B and is currently unprofitable, with a trailing twelve-month EPS of -12.24. Despite a 6.8% revenue increase in the trailing twelve months, the company’s net margin remains at -32.8%. The stock has traded between $11.43 and $35.83 over the past 52 weeks. The recent decline to $27.35 places it near the lower end of its 52-week range. The stock’s beta of 0.64 indicates it is less volatile than the broader market. There has been minimal social media chatter, with only one post in the last 24 hours and one in the past week.
The stock is scheduled to report no further earnings in the near term. Investors should monitor the breadth of coverage and analyst reactions as the market digests the revised guidance and ongoing financial performance.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
Acadia Healthcare (ACHC) Q2 2026 earnings call highlights: guidance update, free cash flow, EBITDA, bed expansion and key risks.
Acadia Healthcare Company, Inc. (ACHC) Q2 2026 Earnings Call July 29, 2026 9:00 AM EDTCompany ParticipantsDebra Osteen - CEO & DirectorDavid Duckworth -...
2026-07-29. The following slide deck was published by Acadia Healthcare Company, Inc.
Filed: 2026-07-28 AccNo: 0001437749-26-024693 Size: 3 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
ACADIA HEALTHCARE CO (ACHC) is down -16.34% in the latest session. Our newswire has captured 4 stories on ACHC across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 53/100). The most recent driver: "Acadia forecasts $3.4B-$3.45B revenue and 500-600 beds in 2026 with focus on free cash flow" (Seeking Alpha).
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of ACHC coverage reads 53/100 over 4 stories; treat it as a research signal and do your own diligence.
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More on ACHC: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier ACHC move explainers: 2026-07-30 · 2026-07-29